Type 1 telemedicine taking off 

A study has given insights into the use and perception of telemedicine during the COVID-19 pandemic among people with Type 1 diabetes. 

Researchers from the University of Bern, Switzerland distributed an online questionnaire via social media between 24 March and 5 May 2020 – 7,477 people from 89 countries responded, and the majority were from the USA (40.6%), UK (17.5%), or Switzerland (9.8%). 

Overall, 28% said they had taken part in remote consultations, while 31% said they planned to use telemedicine in the future, and approximately 80–90% of respondents thought telemedicine was useful. 

“Type 1 diabetes might be particularly well suited to telemedicine because a lot of consultations are mostly based around review of glucose data and conversations about therapy,” and there is “increasing use of continuous glucose monitoring, insulin pumps, and smart insulin pens alongside cloud- or screen-based data-sharing,” said co-author Sam Scott at the virtual European Association for the Study of Diabetes (EASD) conference in September.  

Read more HERE.



Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).
Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags